Beyond clinical: Boosting recruitment and retention with SDOH data
The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care. Social determinants of health (SDOH) – including housing, health literacy, transportation, and social support – can significantly influence participant recruitment and retention, as well as the overall quality of the data collected.
Join pharmaphorum on Wednesday, October 2nd (1:00pm ET / 10:00am PT / 6:00pm BST) for a webinar, developed in association with Socially Determined, to discover how industry leaders are harnessing non-clinical data to enhance recruitment, retention, and broader evidence generation.
Our expert speakers, including Trenor Williams, MD, CEO and co-founder of Socially Determined, Thad Wolfram, President of EmVenio, and Ryan Moog, Head of Life Sciences Solutions for Datavant, will guide you through real-world examples, demonstrating how to identify and overcome obstacles that traditional clinical data might miss, leading to more inclusive and effective studies.
In this webinar, you’ll gain:
- Insights into cutting-edge SDOH data
- Strategies to improve patient engagement throughout the trial lifecycle
- Tools to connect disparate data assets for enhanced understanding of trial populations
- A competitive edge in designing patient-centric clinical trials
- Lessons with applicability to broader research initiatives beyond clinical trials
Register now to reserve your spot. Don’t miss this chance to learn how SDOH data can help you create more successful and meaningful clinical trials.
About the panel
Trenor Williams, MD, CEO and Co-founder of Socially Determined.
Dr. Williams is a family physician, entrepreneur, former health system executive and consulting leader, and past founder and CEO of Clinovations which he sold to the Advisory Board Company in 2014. In 2017, Dr. Williams co-founded Socially Determined to create an analytics platform that integrates the social determinants of health with clinical and claims data to quantify and visualise social risk and the specific impacts on health and healthcare outcomes. Dr. Williams’ unique perspective is formed at the intersection of healthcare and technology. He has an extensive understanding and knowledge in the implementation of healthcare technology, health plan market growth and SDOH strategy development for leading healthcare stakeholders. He holds a Bachelor of Science in Biology from Virginia Polytechnic Institute and received his Medical Doctorate from Marshall University.
Ryan Moog, Head of Life Sciences Datavant
Ryan is the Head of Life Sciences Solutions at Datavant. He has 15 years of experience at the intersection of life sciences, healthcare and technology, working in strategy and product leadership roles in support of clinical innovation and real-world evidence generation. Prior to Datavant, Ryan served as Senior Director of Clinical Trial and Real-World Data Products at Cerner (now Oracle Health). Ryan graduated with a BS in Biology from Butler University and an MBA in Strategy & Management from the University of Kansas.
Thad Wolfram, President, EmVenio Research
With a foundation of more than 20+ years in clinical trials, healthcare, and the pharmaceutical industry, Thad Wolfram brings a wealth of knowledge and experience to EmVenio. As President, he is focused on the growth of hybrid and decentralized trial capabilities and increased clinical trial diversity inclusion, improving the health and lives of patients. Before joining EmVenio, he was Executive Director, Corporate Strategy and Development at PPD, leading several initiatives focused on disruption and the future of clinical trials. Thad also held various senior leadership positions in consulting centered on science and research at EY and PA Consulting Group. He earned his MBA at Rensselaer Polytechnic Institute – The Lally School of Management in Innovation and Strategic Management, an MS at Michigan State University in Industrial Microbiology / Medical Microbiology, and a BS in Microbiology and Molecular Genetics from Michigan State University.
Eloise McLennan, Deep Dive editor (moderator)
Eloise McLennan is the editor for pharmaphorum’s Deep Dive magazine. She has been a journalist and editor in the healthcare field for more than five years and has worked at several leading publications in the UK.
* When you click to register for this webinar you will be taken to a website run by BrightTalk who host the webinar and gather your registration data.
This data may then be passed to pharmaphorum media limited, and in turn passed to the company(ies) we are partnering with to bring you the webinar. This data may be used by us and them for occasional marketing purposes. It will not be shared with any further third parties.
By clicking to register for this webinar you give consent for any data you provide to be used in this way.
If at any point you no longer wish to be contacted based on the information you provide during the registration for this webinar, please send an email to info@pharmaphorum.com requesting that your information is deleted in accordance with the General Data Protection Regulation.
